FDA Alerts

Primary care practitioners should be aware of 3 new FDA approvals that may be useful when treating patients with opioid dependence, prostate cancer, and multiple sclerosis.

A safety review showed that when fluoroquinolones were used systemically, they were associated with disabling and potentially permanent serious adverse effects.

The FDA has warned that the antipsychotic drug, olanzapine, may be associated with a rare but serious skin reaction.

The FDA finalized a rule extending its authority to all tobacco products, including e-cigarettes, cigars, hookah tobacco, and pipe tobacco, among others.

The FDA told manufacturers of a drug/device combination to treat schizophrenia they must provide more information before the product can be considered for approval.

In response to evidence from several large trials, the FDA has decided to withdraw its approval of niacin and fibrate in combination with statins.

The FDA has approved folic acid fortification of corn masa flour, used in the production of tortillas, tortilla chips, tamales, taco shells, and corn chips.

The FDA has required labeling changes regarding recommendation of metformin treatment in patients with reduced kidney function.

The FDA has issued a new warning concerning heart failure risk associated with the use of 2 type 2 diabetes medicines.

...